Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Millions of photoreceptor cells in the eye are responsible for converting light into signals that can be transmitted to the brain and processed. When these cells malfunction or are damaged, vision loss often results.
Laboratory tests over the past two decades have shown that when photoreceptors are transplanted into the retina (i.e., the light-sensitive layer of tissue at the back of the eye) vision loss can be reversed.
Dr. Valerie Wallace, Co-Director and Senior Scientist at UHN's Donald K. Johnson Eye Institute, and her research team have observed a phenomenon that helps explain how these cells restore vision.
"Transplanted cells rarely integrate into the retina, yet they are somehow still able to rescue vision," says Dr. Arturo Ortin-Martinez, a scientific associate in Dr. Wallace's lab and the lead author of the study. "Understanding this process will enable us to improve the success of transplants."
The researchers found that donor cells form microscopic, tunnel-like bridges – called nanotubes – with the host photoreceptors. Materials that are essential to photoreceptor function can move between the cells via these nanotubes.
Using microscopy techniques that can track proteins and other components of cells, the team observed the nanotubes forming and extending as protrusions from the donor cells towards the recipient cells. They then saw materials moving between the cells.
Among the techniques used to gain this insight was an exciting method developed by Dr. Wallace's group called InVision. This method makes eye tissue transparent, enabling researchers to image whole eyes, rather than thin sections of tissue. After examining the eye at this scale, the team concluded that around 80 per cent of the donated photoreceptors formed nanotubes with host photoreceptors.
When tracking the movement of cellular materials, the researchers found that the amount of material transferred to the host cells depended on the persistence of the donor cells – more material was transferred when the cells survived longer. The research team also discovered that materials were only transferred when the donor cells were photoreceptors; materials were rarely transferred from other types of cells, such as brain neurons.
"We think that this exchange helps restore vision in transplant recipients by supplying materials that are missing in the damaged retina," says Dr. Wallace. "Next we need to explore what cargo is moving between cells and how we can optimize the transfer process."
Because photoreceptors are a type of nerve cell, these new observations may impact the design of cell-based strategies for treating degeneration in other parts of the nervous system.
This work was supported by the Ontario Institute of Regenerative Medicine, Medicine by Design at the University of Toronto, the Krembil Foundation and the UHN Foundation. V Wallace holds a Tier 1 Canada Research Chair in Retina Regeneration.